Hydrochloric Acid

Hydrochloric Acid

SCHEMBL8466664

C=[N+](C)C.Cl.[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL443366 0.94
SCHEMBL22288234 0.67
Hydrochloric Acid SCHEMBL28888828 0.64
SCHEMBL21829069 0.64
SCHEMBL14328614 0.62
Hydrochloric Acid SCHEMBL8466661 0.62
SCHEMBL10033471 0.62
SCHEMBL83415 0.62
Hydrochloric Acid SCHEMBL7220279 0.53
Hydrochloric Acid SCHEMBL4534886 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4789489-A WITH IONENE POLYMER BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1988-12-06 US claimed
US-10633573-B2 Composition and method for inhibition of sulfide scales CLARIANT INTERNATIONAL LTD. (CH) 2020-04-28 US disclosed
EP-3277771-B1 COMPOSITION AND METHOD FOR INHIBITION OF SULFIDE SCALES CLARIANT INT LTD (CH) 2019-05-08 EP disclosed
US-20180105732-A1 Composition And Method For Inhibition Of Sulfide Scales CLARIANT INTERNATIONAL, LTD. (CH) 2018-04-19 US disclosed
EP-3277771-A1 COMPOSITION AND METHOD FOR INHIBITION OF SULFIDE SCALES Clariant International Ltd (CH) 2018-02-07 EP disclosed
WO-2016155967-A1 COMPOSITION AND METHOD FOR INHIBITION OF SULFIDE SCALES CLARIANT INTERNATIONAL LTD (CH) 2016-10-06 WO disclosed
WO-2016134873-A1 LIQUID DISSOLVER COMPOSITION, A METHOD FOR ITS PREPARATION AND ITS APPLICATION IN METAL SULFIDE REMOVAL CLARIANT INTERNATIONAL LTD (CH) 2016-09-01 WO disclosed
CN-103058883-B Preparation technology of solid (chlorine methylene) dimethyl ammonium chloride SHANDONG KAISHENG NEW MATERIALS CO LTD 2015-01-21 CN disclosed
CN-103058883-B Preparation technology of solid (chlorine methylene) dimethyl ammonium chloride SHANDONG KAISHENG NEW MATERIALS CO LTD 2015-01-21 CN disclosed
WO-2014110696-A1 PROCESS FOR PREPARING SOLID (CHLORINE METHYLENE) DIMETHYL AMMONIUM CHLORIDE 山东凯盛新材料股份有限公司 (CN) 2014-07-24 WO disclosed
CN-103058883-A Preparation technology of solid (chlorine methylene) dimethyl ammonium chloride SHANDONG KAISHENG NEW MATERIALS CO LTD 2013-04-24 CN disclosed
CN-103058883-A Preparation technology of solid (chlorine methylene) dimethyl ammonium chloride SHANDONG KAISHENG NEW MATERIALS CO LTD 2013-04-24 CN disclosed
US-20120295887-A1 PHARMACEUTICALLY ACCEPTABLE SALTS OF PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND MEDICAL USE THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2012-11-22 US disclosed
US-6008236-A MICROBIOCIDE MIXTURE FOR CONTROLLING THE GROWTH OF MICROORGANISMS AND PREVENT SPOILAGE CAUSED BY MICROORGANISMS BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1999-12-28 US disclosed